A class-action lawsuit has been filed against CVS Health, Caremark and Aetna to recover millions of dollars for independent pharmacies in what lawyers say are wrongfully assessed pharmacy DIR fees for Medicare Part D prescriptions.
The suit claims that Caremark violated federal antitrust laws and state laws governing contracts while assessing DIR fees. The lawsuit also claims Caremark’s arbitration agreement is unenforceable.
NCPA will provide more information on the case as it develops. In the meantime, the lawyers representing the independent pharmacies will be at the NCPA Annual Convention in Orlando, October 14-17. If you would like to join the class-action lawsuit, this will be your first chance to speak to the attorneys. They will be available to meet with you privately to discuss other actions you can take to recoup wrongfully assessed DIR fees.
Remember, AAP Members and API Customers can save $100 when using the promo code “Buy100.” Register for the convention here.